Literature DB >> 11702155

MR imaging evaluation of suprascapular nerve entrapment.

T Ludig1, F Walter, D Chapuis, D Molé, J Roland, A Blum.   

Abstract

The aim of this study was to assess the significance of muscular edema, atrophy, and fatty changes in the diagnosis of suprascapular nerve entrapment (SSNE), and to confirm muscular edema as the most significant sign of neuropathy. A retrospective study of 18 patients with suprascapular nerve entrapment was performed. All patients underwent electromyographic studies and MR imaging with a 1.5-T Echo Speed system (General Electric, Milwaukee, Wis.). The diagnosis of muscle edema was reached when muscles presented a high signal on T2-weighted fast spin-echo (SE) fat-suppressed images. Muscular trophicity and fatty changes were analyzed on a sagittal oblique cut using SE T1-weighted images. Intra- and inter-observer reproducibility using kappa test, sensitivity, and specificity were analyzed, together with negative and positive predictive value of each criterion. The topographic diagnosis was correct as edema affected the infraspinatus muscle alone when the suprascapular nerve was entrapped at the spinoglenoid notch. Both the supraspinatus and infraspinatus muscles were affected when nerve was compressed at the suprascapular notch. Sensitivity and specificity of muscular edema were, respectively, 94.5 and 100%. Muscular atrophy sensitivity and specificity were 81 and 80%, respectively. Fatty changes sensitivity and specificity were 25 and 96%, respectively. Muscular edema seems to be a more sensitive sign of SSNE than muscle atrophy and fatty changes when compared with EMG results. Magnetic resonance imaging can reach a positive, topographic, and etiologic diagnosis of SSNE.

Entities:  

Mesh:

Year:  2001        PMID: 11702155     DOI: 10.1007/s003300100968

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  9 in total

1.  [Shoulder pain and muscle weakness].

Authors:  G Andreisek; A Studer; D Weishaupt
Journal:  Radiologe       Date:  2006-02       Impact factor: 0.635

Review 2.  Multimodality imaging of the postoperative shoulder.

Authors:  Klaus Woertler
Journal:  Eur Radiol       Date:  2007-05-22       Impact factor: 5.315

3.  MR imaging findings of anterior interosseous nerve lesions.

Authors:  Andrew J Dunn; David C Salonen; Dimitri J Anastakis
Journal:  Skeletal Radiol       Date:  2007-10-16       Impact factor: 2.199

4.  A retrospective review of 112 patients undergoing arthroscopic suprascapular nerve decompression.

Authors:  Franklin B Davis; Yoshihiro Katsuura; John A Dorizas
Journal:  J Orthop       Date:  2019-11-27

5.  New parameters describing morphological variations in the suprascapular notch region as potential predictors of suprascapular nerve entrapment.

Authors:  Michał Podgórski; Mirosław Topol; Marcin Sibiński; Piotr Grzelak; Ludomir Stefańczyk; Michał Polguj
Journal:  BMC Musculoskelet Disord       Date:  2014-11-25       Impact factor: 2.362

Review 6.  Classification of full-thickness rotator cuff lesions: a review.

Authors:  Alexandre Lädermann; Stephen S Burkhart; Pierre Hoffmeyer; Lionel Neyton; Philippe Collin; Evan Yates; Patrick J Denard
Journal:  EFORT Open Rev       Date:  2017-03-13

7.  Evaluation of neuropathy during intensive vincristine chemotherapy for non-Hodgkin's lymphoma and Acute Lymphoblastic Leukemia.

Authors:  M Dorchin; R Masoumi Dehshiri; S Soleiman; M Manashi
Journal:  Iran J Ped Hematol Oncol       Date:  2013-10-22

8.  Suprascapular Notch asymmetry: a study on 311 patients.

Authors:  Michał Polguj; Marcin Sibiński; Andrzej Grzegorzewski; Piotr Grzelak; Ludomir Stefańczyk; Mirosław Topol
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

9.  Variation in morphology of suprascapular notch as a factor of suprascapular nerve entrapment.

Authors:  Michał Polguj; Marcin Sibiński; Andrzej Grzegorzewski; Piotr Grzelak; Agata Majos; Mirosław Topol
Journal:  Int Orthop       Date:  2013-07-27       Impact factor: 3.075

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.